Procarta awarded £7.4M for microbial treatment

  25 September 2019

The company, which has discovered a new type of antimicrobial that kills bacteria by blocking their gene expression, was awarded the funding by CARB-X, a global partnership dedicated to accelerating early antimicrobial R&D.

Further reading: Laboratory News
Author(s): Laboratory News
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed